Genscript Biotech Co. (OTCMKTS:GNNSF) Sees Large Decline in Short Interest

Genscript Biotech Co. (OTCMKTS:GNNSF) was the recipient of a large drop in short interest in the month of May. As of May 31st, there was short interest totalling 6,557,600 shares, a drop of 5.7% from the May 15th total of 6,955,800 shares. Based on an average daily trading volume, of 154,500 shares, the short-interest ratio is currently 42.4 days.

Genscript Biotech Price Performance

Genscript Biotech stock opened at C$1.05 on Wednesday. The company’s 50-day moving average price is C$1.41 and its two-hundred day moving average price is C$1.95. Genscript Biotech has a 52 week low of C$1.05 and a 52 week high of C$3.20.

About Genscript Biotech

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.